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Variable
Resolved Improved No change
p-value
Mean  SD,
or N (%)
Mean  SD,
or N (%)
Mean  SD,
or N (%)
Total patients 6 (100%) 5 (100%) 6 (100%) -
Age 59.9  14.8 58.2  12 69.3  14 0.36
BMI (kg/m2) 28.7  6.8 31.6  4.5 29.1  7.6 0.74
SaO2 resting (%, pre-
procedure)
89.2  7.1 90.7  7.1 83.2 5.4 0.31
SaO2 in the upright position
(%, pre-procedure)
75.7  5.9 76.7  4.9 76  6.9 0.98
PFO canal height on cath
(mm)
10.3  3.2 8.5  3.1 11.5  4.9 0.61
Presence of atrial septal
aneurysm
0 (0%) 1 (20%) 2 (33.3%) 0.47
Presence of residual shunt 1 (16.7%) 1 (20%) 2 (33.3%) 0.47
SaO2 resting (%, post-
procedure)
96.8  1.9 94.4  1.5 87.2  3.5 <0.0001
SaO2 in the upright position
(%, post-procedure)
95.8  2.8 87.6  9.3 78.5  4.9 0.033
Mean pulmonary pressure
(mm Hg, pre-cath)
32.3  16.5 26.4  8.8 51.4  16.8 0.06
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: PFO closure may resolve symptomatic postural dyspnea and hypoxemia
and is an effective method for treating OPS.
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Background: Patent foramen ovale (PFO) is a remnant of normal fetal development
that persists inw25% of the population. It is a canal connecting the atria that allows the
transit of blood from venous to arterial circulation, bypassing the pulmonary circuit.
PFO is associated with cryptogenic stroke, migraine, visual auras, and other medical
conditions. Based on the analysis of family pedigrees, previous studies suggest that
PFO is an inherited condition. The aim of this novel study was to elucidate the speciﬁc
genes involved in maintaining patency of the foramen ovale after birth.
Methods: Medical records of patients with identiﬁed PFO were reviewed for family
history of PFO prevalence. Of 750 patients with PFO, 26 families were identiﬁed
having multiple members diagnosed with PFO. Five families (16 individuals) were
recruited for genetic testing. PFO was diagnosed using transcranial Doppler imaging
with agitated saline. Serum DNA was collected from the 16 subjects, and was
analyzed using exome sequencing. A two-tailed t-test analysis was used to compare
the mutations between the groups of those with PFO and those without PFO; p value
< 0.001 was considered as statistically signiﬁcant.
Results: In the ﬁve families (16 individuals) with available DNA samples, PFO was
found in 10 patients (62.5%). Exome sequencing revealed 25 mutations on 13 unique
chromosomes that demonstrated statistically signiﬁcant differences between the two
groups of those with PFO and those without PFO (p¼0.0002).
Conclusions: Genetic sequencing provides speciﬁc mutations that are linked to
patency of the foramen ovale. Further genetic testing on more families is ongoing.
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Background: Recently revised instructions for use suggested that patients with
inferior vena cava (IVC) rim deﬁciency should be considered as contraindication of
transcatheter closure of atrial septal defect because of risk of cardiac erosion. Con-
ventional balloon sizing technique may produce the over sizing of device selection in
this anatomical condition. However, concern still remains the relationship between
IVC rim deﬁciency and complications.
Methods: Methods: From 2007 through 2013, 476 consecutive patients with ASD
were performed transcatheter ASD closure using Amplatzer Septal Occluder. Patients
were divided into 2 groups (with or without IVC rim deﬁciency) using trans-
esophageal echocardiographic evaluation. ASD diameter, selected device size, pro-
cedure success rate, complications (device migration, erosion) were evaluated. In
patients with IVC rim deﬁciency, 3-4 mm larger sized device was selected without
balloon sizing technique. Contrary, balloon sizing technique was used for device
selection in patients without IVC rim deﬁciency.B48 JACC Vol 64/11/Suppl B j September 1Results: Patients with IVC rim deﬁciency had signiﬁcantly larger defect size and
increased Qp/Qs ratio compared to patients without IVC rim deﬁciency. Although
patients with IVC rim deﬁciency had signiﬁcantly lower procedure success rate, more
than 90% patients with IVC deﬁciency could be treated with low complication rate
such as device migration or cardiac erosion. (Table)Conclusions: Under the appropriate device selection and device deployment tech-
nique, majority of patients with IVC rim deﬁciency can be treated by transcatheter
closure with low complication rate.
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Background: Despite several negative prospective randomized trials on the efﬁcacy
of patent foramen ovale (PFO) occlusions the discussion on the validity of these
studies and on new indications is ongoing. We investigated the risk of paradoxical
embolic myocardial infarction over a time period of more than 13 years.
Methods: Our effort to describe the epidemiology of paradoxical embolic myocardial
infarction included a retrospective and a prospective approach: We analyzed retro-
spectively the incidence of paradoxical coronary embolism over 10 years and then
prospectively undertook the effort to prove this using the same methodology over 39
months in another center. All patients with acute myocardial infarction (AMI) ac-
cording to ECG criteria and elevation of cardiac troponin or creatin kinase and normal
coronary arteries were screened for PFO and if no other reasons for the AMI could be
found after thorough work-up, were judged as presumed paradoxical embolism.
Results: In a retrospective analysis over 10 years amongst 4848 AMIs 22 patients
(0.45 %) were identiﬁed to have had presumed paradoxical embolic pathogenesis
based on strict criteria of absence of arrhythmias and virtual absence of atherosclerosis
in any vascular territory. To further elucidate the epidemiologic size of this disease
entity we prospectively studied 1654 AMIs in another tertiary referral center over a
time period of 39 months and found an incidence of 13 presumed paradoxical embolic
AMIs (0.79 %) based on application of the same criteria. The patients in the para-
doxical embolic cohorts were younger (45.7  11.5 years) as compared to the overall
AMI population (65.0  13.2 years), most likely based on the criteria applied
(exclusion of detectable atherosclerosis).
Conclusions: Paradoxcial embolism through a PFO is the most likely cause of AMI in
roughly 5/1000 patients. While this is a rather low rate, the incidence is still high
enough to warrent clinical attention.3–17, 2014 j TCT Abstracts/Congenital Heart Disease - PFO and ASD
